deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT03225989

Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer

Phase I/II Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer

Sponsor: Lokon Pharma AB

Conditions Biliary Carcinoma Colorectal Cancer Ovarian Cancer Pancreatic Adenocarcinoma
Interventions LOAd703
Updated 14 times since 2017 Last updated: Oct 25, 2024 Started: Mar 1, 2018 Primary completion: Aug 22, 2023 Completion: Aug 22, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03225989, this PHASE1/PHASE2 trial focuses on Biliary Carcinoma and Colorectal Cancer and remains completed. Sponsored by Lokon Pharma AB, it has been updated 14 times since 2018, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Aug 2017 – ~Mar 2018 · 7 months · monthly snapshot~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshot~Jun 2018 – ~Sep 2019 · 15 months · monthly snapshot~Sep 2019 – ~Nov 2019 · 2 months · monthly snapshot~Nov 2019 – ~Mar 2020 · 4 months · monthly snapshot~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~May 2022 · 13 months · monthly snapshot~May 2022 – ~May 2023 · 12 months · monthly snapshot~May 2023 – ~Mar 2024 · 10 months · monthly snapshot~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshot~Dec 2024 – present · 21 months · monthly snapshot

Change History

14 versions recorded

  1. Dec 2024 — Present [monthly]

    Completed PHASE1/PHASE2

    Status: Active Not Recruiting → Completed

  2. Sep 2024 — Dec 2024 [monthly]

    Active Not Recruiting PHASE1/PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  4. Mar 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  5. May 2023 — Mar 2024 [monthly]

    Active Not Recruiting PHASE1_PHASE2

    Status: Recruiting → Active Not Recruiting

▶ Show 9 earlier versions

  1. May 2022 — May 2023 [monthly]

    Recruiting PHASE1_PHASE2

  2. Apr 2021 — May 2022 [monthly]

    Recruiting PHASE1_PHASE2

  3. Jan 2021 — Apr 2021 [monthly]

    Recruiting PHASE1_PHASE2

  4. Mar 2020 — Jan 2021 [monthly]

    Recruiting PHASE1_PHASE2

  5. Nov 2019 — Mar 2020 [monthly]

    Recruiting PHASE1_PHASE2

  6. Sep 2019 — Nov 2019 [monthly]

    Recruiting PHASE1_PHASE2

  7. Jun 2018 — Sep 2019 [monthly]

    Recruiting PHASE1_PHASE2

  8. Mar 2018 — Jun 2018 [monthly]

    Recruiting PHASE1_PHASE2

    Status: Not Yet Recruiting → Recruiting

  9. Aug 2017 — Mar 2018 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Lokon Pharma AB
  • Uppsala University
Data source: Lokon Pharma AB

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations